Healthcare - Biotechnology - NASDAQ - US
$ 42.18
-15.6 %
$ 5.03 B
Market Cap
-14.65
P/E
INCOME STATEMENT
9.56 M
REVENUE
-236 M
OPERATING INCOME
-212 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Avidity Biosciences, Inc.
| Revenue | 9.56 M |
| Cost Of Revenue | 191 M |
| Gross Profit | -181 M |
| Operating Expenses | 245 M |
| Operating Income | -236 M |
| Other Expenses | -23.4 M |
| Net Income | -212 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 9.6 | 9.2 | 9.3 | 6.8 | 2.3 | 0.4 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 191.0 | 1.4 | 0.6 | 37.6 | 14.5 | 8.4 |
| Gross Profit | (181.4) | 7.8 | 8.7 | (30.8) | (12.2) | (8.1) |
| OPERATING INCOME | ||||||
| Operating Expenses | 245.2 | 188.1 | 127.4 | 51.1 | 19.7 | 10.9 |
| Selling, General and Administrative Expenses | 54.2 | 37.7 | 26.2 | 13.5 | 5.1 | 2.4 |
| Research and Development Expenses | 191.0 | 150.4 | 101.2 | 37.6 | 14.5 | 8.4 |
| Operating Income | (235.6) | (178.9) | (118.1) | (44.3) | (17.3) | (10.5) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 0.2 | 7.4 | 0.7 |
| Total Other Income | 23.4 | 4.9 | 42 K | 78 K | (7.4) | (0.7) |
| Pre-Tax Income | (212.2) | (174.0) | (118.0) | (44.4) | (24.7) | (11.2) |
| NET INCOME | ||||||
| Tax Provision | 0 | (4.9) | (0.6) | (0.4) | 7.4 | 0.7 |
| Net Income | (212.2) | (169.1) | (117.4) | (44.0) | (32.1) | (11.9) |
| EPS | 2.91 | 3.24 | 2.83 | 2.03 | 0.86 | 0.58 |